Nkarta Inc NKTX

‎$‎1.970(0%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Nkarta Inc
Today

Create an eToro account to buy NKTX stock on a secure, user-friendly, multi-asset trading platform.

Nkarta Inc NKTX

Buy NKTX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Colliers International Group Inc

‎$‎113.39

-4.09%

SWR.L

Smurfit WestRock Public Limited Company

3,760.35‎p‎

-1.31%

REINA.NV

Reinet Investments SCA

‎€‎31.60

+9.72%

FBIN

Fortune Brands Innovations Inc

‎$‎51.32

-17.62%

ICLR

ICON Public Limited Company

‎$‎93.00

+16.13%

MAX

*Past performance is not an indication of future results

Jump to:

About NKTX >
How to Buy? >
Top Guides >

The Nkarta Inc share price is on the decline this week.

The Nkarta Inc share price today is ‎$‎1.97, reflecting a ‎0‎% change over the last 24 hours and ‎-2.50‎% over the past week. The current market capitalization of NKTX is ‎$‎139.93M with an average volume in the last three months of 736542.45. The stock has a P/E ratio of -1.42 and a dividend yield of 0%. With the stock’s beta sitting at 1.4

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

NKTX Key Metrics

Market Cap

‎$‎139.93M

Day’s Range

‎$‎1.93 - ‎$‎1.99

52W Range

‎$‎1.29 - ‎$‎6.61

Average Volume (3M)

736542.45

Price-Earnings Ratio

-1.42

Revenue

‎$‎0

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎1.97

EPS

‎$‎-1.39

Beta

1.4

How can I buy Nkarta Inc stocks?

To purchase Nkarta Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Nkarta Inc (NKTX) page and place an order to buy Nkarta Inc.

Buy NKTX

Looking for more information? Check out our guide on Academy.

What Is Nkarta Inc?

Nkarta Inc is a pioneering biopharmaceutical company focused on the clinical development of engineered natural killer (NK) immune cell therapies to treat cancer. It serves North America.

Operating in the biotechnology sector, Nkarta Inc has made notable strides in the industry. It has pioneered NK cell therapies using innovative, proprietary cell engineering technologies. It focuses on the development of robust cancer treatment modalities, contributing significantly to advancements in the medical field.

Diversify your virtual portfolio by following NKTX shares on eToro.

CEO

Paul J. Hastings

Employees

157

Founded

2005

South San Francisco, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Nkarta Inc
Today

Create an eToro account to buy NKTX stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Nkarta Inc stock?

The current price of NKTX is ‎$‎1.97.

What are analysts’ forecasts for Nkarta Inc?

Analysts offer forecasts for Nkarta Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Nkarta Inc?

The market capitalisation of Nkarta Inc is ‎$‎139.93M

Daily Movers

Explore the biggest stocks movers on the market.